<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01748630</url>
  </required_header>
  <id_info>
    <org_study_id>TOTM_Anaesthesia_MSA1</org_study_id>
    <nct_id>NCT01748630</nct_id>
  </id_info>
  <brief_title>Effects of Dexmedetomidine on the Postoperative Experience in Children</brief_title>
  <official_title>Pain, Fentanyl Consumption, and Delirium in Children After Scoliosis Surgery: Dexmedetomidine Versus Midazolam</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inonu University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inonu University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: The study aim was to compare the efficacy of dexmedetomidine versus midazolam for
      sedation during the early postoperative period in children who underwent scoliosis surgery.

      Methods: We performed a prospective, randomized trial in an intensive care unit (ICU) in a
      tertiary care center. In this study, 42 patients (American Society of Anesthesiology physical
      status I and II) who underwent scoliosis surgery were divided into 2 groups according to
      sedation protocols: group DEX (n = 22) and group MDZ (n = 20). Children (12-18 years)
      requiring mechanical ventilation underwent a continuous infusion of either dexmedetomidine
      (group DEX; starting dose, 0.4 μg•kg-1•h-1) or midazolam (group MDZ; starting dose, 0.1
      mg•kg-1•h-1) with intermittent fentanyl, as needed. The efficacy of sedation was assessed
      using the Richmond Agitation Sedation Scale (RASS). Quality of pain relief was measured using
      the Numeric Visual Analog Scale (NVAS). During the arousal assessment, delirium was
      determined in patients in the RASS range of -2 to +1 using the Confusion Assessment Method
      for the ICU (CAM-ICU). Fentanyl consumption, incidence of delirium, NVAS scores, and
      hemodynamics were recorded postoperatively at 2, 4, 6, and 24 h in the ICU.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fentanyl consumption</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fentanyl consumption</measure>
    <time_frame>2 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fentanyl consumption</measure>
    <time_frame>4 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fentanyl consumption</measure>
    <time_frame>6 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>fentanyl consumption</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of delirium</measure>
    <time_frame>1, 2, 4 ,6 and 24 hours</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>heart rate</measure>
    <time_frame>1, 2, 4 ,6 and 24 hours</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Failed Moderate Sedation During Procedure</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine, Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexmedetomidine (group DEX); starting dose, 0.4 μg•kg-1•h-1,with intermittent fentanyl</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>midazolam (group MDZ); starting dose, 0.1 mg•kg-1•h-1</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine</intervention_name>
    <arm_group_label>Dexmedetomidine, Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fentanyl</intervention_name>
    <arm_group_label>Dexmedetomidine, Midazolam</arm_group_label>
    <arm_group_label>Midazolam</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        admittance to the ICU and a requirement of mechanical ventilation with an endotracheal
        tube.

        Exclusion Criteria:

        Patients who had a history of allergies to midazolam and/or dexmedetomidine; delirium,
        developmental delay, or mental retardation, as reported by parents; an American Society of
        Anesthesiologists classification greater than III; any known previous reactions to
        anesthesia; or a history of asthma or an anticipated difficult airway and concomitant
        disease (neuromuscular scoliosis or neurodegenerative disease) were excluded from the
        study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Inonu University Turgut Ozal Medical Center</name>
      <address>
        <city>Malatya</city>
        <zip>44280</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2012</study_first_submitted>
  <study_first_submitted_qc>December 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2012</study_first_posted>
  <last_update_submitted>December 11, 2012</last_update_submitted>
  <last_update_submitted_qc>December 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Inonu University</investigator_affiliation>
    <investigator_full_name>Dr Mustafasaid</investigator_full_name>
    <investigator_title>Assist. Prof.</investigator_title>
  </responsible_party>
  <keyword>scoliosis, sedation, children, fentanyl consumption, pain</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

